Skip to content

Treatment of Nonunion of Limb Fracture With Human Amniotic Epithelial Cells(hAECs)

Treatment of Nonunion of Limb Fracture With Human Amniotic Epithelial Cells(hAECs)

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03031509
Enrollment
36
Registered
2017-01-25
Start date
2017-12-31
Completion date
2020-12-31
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonunion Fracture

Keywords

Nonunion Fracture of limb

Brief summary

The purpose of this study is to evaluate the efficacy and safety of human amniotic epithelial cells transplant in nonunion of limb fracture patients.

Detailed description

In this study, patients of nonunion after limb fracture will be treated with human amniotic epithelial cells. Clinical and radiological assessment is performed. hAECs developing from the epiblast as early as 8 days after fertilization, recent data reported indicate that hAECs possess proper osteogenic differentiation potential and a localized modulatory influence on the early tissue remodeling process, making these cells a promising stem cell source for bone regeneration after fractures.

Interventions

Human Amniotic Epithelial Cells transplant after debridement

PROCEDUREdebridement

debridement

Sponsors

Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
CollaboratorINDUSTRY
Shanghai East Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* diagnosed with nonunion of limbs by x-ray and bone scan; * compliance to treatment and long term follow-up; * be able and willing to participate in the study; * written informed consent before study.

Exclusion criteria

* pregnant or breastfeeding; * patients with malignancy, immunocompromised ( HIV AIDS, Diabetes mellitus, active Hepatitis), in a immunosuppressant therapy ( chemotherapy or steroids), OR health status, mental diseases, which will influence the study; * patients undergoing any other treatment that are not related to this study; * others considered not appropriate selected patients.

Design outcomes

Primary

MeasureTime frameDescription
time for bone union6 monthsBone union was evaluated at 6-month after surgery according to the following definition.Definition of bone union is when simple X-ray findings reveal that bone trabeculae or cortical bone exceeds the fracture site.

Secondary

MeasureTime frame
pain in fracture site1 year
limb functional score1 year

Countries

China

Contacts

Primary ContactXia LI, Dr.
daxia868@163.com86-21-38804518

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026